Chloe Botaine

A routine chest X-ray, long a staple of diagnostic medicine for detecting overt disease, now holds the potential to reveal a far deeper truth about our health: the hidden pace at which our bodies are truly aging. The use of Artificial Intelligence to estimate biological age represents a significant

We are joined today by biopharma expert Ivan Kairatov to discuss a groundbreaking development in the fight against a virus that over 80% of the global population carries, often without a clue: human cytomegalovirus, or HCMV. While dormant for most, this stealthy pathogen poses a life-threatening

For the first time in more than a decade, the therapeutic landscape for newly diagnosed metastatic HER2-positive breast cancer has been fundamentally altered by a landmark U.S. Food and Drug Administration decision. The agency has officially approved a combination therapy featuring Enhertu and

A groundbreaking predictive model is set to fundamentally alter how clinicians manage metastatic hormone-sensitive prostate cancer (mHSPC), offering a new beacon of clarity in a field often clouded by uncertainty. This innovative artificial intelligence tool, developed by a team of leading

Beyond the primary battle against tumors, many cancer patients face a debilitating secondary war against cachexia, a profound wasting syndrome that silently erodes the body and spirit. This severe metabolic condition, marked by unintentional weight loss and muscle deterioration, significantly

I'm Ivan Kairatov, and my work takes me deep into a world most people never see, yet it's critical to all of us: the microbial ecosystem inside our wastewater treatment plants. For decades, we've thought of these facilities as simple filters, removing pollutants and a few known bacteria. But our

A comprehensive global study has brought to light the profound and deeply concerning disparities in survival rates among children diagnosed with cancer, revealing a stark divide that correlates directly with a country's socioeconomic development. The research, which aggregates data from numerous

The landscape of oncology funding is undergoing a profound and strategic transformation, moving decisively away from supporting purely theoretical research toward projects with a clear and direct path to real-world application. Grant-making organizations are now signaling a clear preference for

The landscape of cancer immunotherapy was shaken as Arcus Biosciences announced the termination of a pivotal Phase 3 trial for its TIGIT-targeting drug, domvanalimab. The decision, prompted by a finding of "futility," delivers a significant setback to its partner Gilead Sciences and casts further

The silent progression of the hepatitis C virus (HCV) has long posed a formidable public health challenge, largely due to a slow and fragmented diagnostic process that creates a critical bottleneck in patient care. The current standard involves a two-step ordeal that can stretch over days or even